4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-021746
Chairman and CEO bought 19,200 shares at an average $1.11 ($21,364)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-03-26 | Purchase | +14,200 | $1.07 | $15,194 | 10,513,043 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-27 | Purchase | +3,500 | $1.21 | $4,235 | 10,516,543 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-30 | Purchase | +1,500 | $1.29 | $1,935 | 10,518,043 | D |
| Open-market purchases · 19,200 sh · avg $1.11 · $21,364 | |||||||
Loading xslF345X03/doc4.xml…